VS
Venkata Satyavani Donavalli
About Venkata Satyavani Donavalli
Data last updated:
Venkata Satyavani Donavalli is a Director at Srinija Drugs Private Limited (since 2023). The company operates in Pharma. Srinija Drugs Private Limited reported revenue of ₹19.09 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Srinija Drugs Private Limited U24233AP2000PTC034263 | Director | 28 Oct 2023 | 2000 | ₹19.09 Cr (FY 2024) | Active |
Board colleagues of Venkata Satyavani Donavalli
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anantha Laxmi Talluri | 07690076 | Srinija Drugs Private Limited | Director |
| Bulli Raju Nekkanti | 01746430 | Srinija Drugs Private Limited | Managing Director |
| Laxmanarao Talluri | 01746373 | Srinija Drugs Private Limited | Director |
| Nekkanti Saraswathi | 07684289 | Srinija Drugs Private Limited | Director |
| Venkata Ramesh Donavalli | 01746408 | Srinija Drugs Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Venkata Satyavani Donavalli
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Venkata Satyavani Donavalli
Venkata Satyavani Donavalli currently holds 1 directorship: Srinija Drugs Private Limited (Director, since 28 Oct 2023, revenue ₹19.09 Cr (FY 2024)).
Venkata Satyavani Donavalli was first appointed on 28 Oct 2023 as Director at Srinija Drugs Private Limited.
The current boards of Venkata Satyavani Donavalli's companies include Anantha Laxmi Talluri (Srinija Drugs Private Limited), Bulli Raju Nekkanti (Srinija Drugs Private Limited), Laxmanarao Talluri (Srinija Drugs Private Limited), Nekkanti Saraswathi (Srinija Drugs Private Limited), Venkata Ramesh Donavalli (Srinija Drugs Private Limited).